This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosuge, K.
Right arrow Articles by Nakashima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosuge, K.
Right arrow Articles by Nakashima, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1998, p. 1298-1302, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Comparative Dispositions of Ofloxacin in Human Head, Axillary, and Pubic Hairs

Kazuhiro Kosuge,1,2 Toshihiko Uematsu,3,* Sei-Ichi Araki,2 Hiroyuki Matsuno,3 Kyoichi Ohashi,1 and Mitsuyoshi Nakashima2

Departments of Clinical Pharmacology1 and Pharmacology,2 Hamamatsu University School of Medicine, Hamamatsu 431-31, and Department of Pharmacology, Gifu University School of Medicine, Gifu 500,3 Japan

Received 3 September 1996/Returned for modification 12 March 1997/Accepted 12 February 1998

The distribution of ofloxacin (OFLX) along the shaft of each of three hair types, i.e., head, axillary and pubic, was investigated and compared among five healthy male volunteers 1 to 4 months after ingestion of OFLX for 1 or 2 days (total dose, 200 or 600 mg). Five strands of each hair type were sectioned together into successive 0.5-cm lengths starting from the dermal end, over a length of <= 6 cm, and the OFLX concentration in each hair section was measured by high-pressure liquid chromatography with fluorescence detection. The distribution of OFLX along the head hair shaft was narrow, having a single peak even 3 to 4 months after administration, suggesting a rather uniform growth rate among hair strands. On the other hand, the OFLX distribution along axillary or pubic hair shafts tended to be broad, even having two apparent peaks, and the growth rate did not seem uniform. Since axillary hair seemed to stop growing after having gained a length of <= 4 to 5 cm, it was suggested to enter a resting stage after the growth of <= 3 cm over the 2 to 4 months after OFLX incorporation. These findings indicate that head hair is the most suitable for analysis of individual drug use and the larger growth rate and cycle stage variabilities of strands of the other types of hair should be taken into account.


* Corresponding author. Mailing address: Department of Pharmacology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500, Japan. Phone: 81-58-267-2231. Fax: 81-58-267-2959. E-mail: uematsu{at}cc.gifu-u.ac.jp.


Antimicrobial Agents and Chemotherapy, May 1998, p. 1298-1302, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hartwig, S., Auwarter, V., Pragst, F. (2003). FATTY ACID ETHYL ESTERS IN SCALP, PUBIC, AXILLARY, BEARD AND BODY HAIR AS MARKERS FOR ALCOHOL MISUSE. Alcohol Alcohol 38: 163-167 [Abstract] [Full Text]  
  • Gandhi, M., Greenblatt, R. M. (2002). Hair It Is: The Long and Short of Monitoring Antiretroviral Treatment. ANN INTERN MED 137: 696-697 [Full Text]